Clinical Trial Update: A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information

View source ↗

Summary

This is a long-term safety follow-up study of adults with growth hormone deficiency treated with Sogroya (somapacitan) to monitor safety over an extended period…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Sogroya (somapacitan)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Adult Growth Hormone Deficiency | Status: ENROLLING_BY_INVITATION